Dirk Thye
Vorstandsvorsitzender bei QUINCE THERAPEUTICS, INC.
Vermögen: 572 236 $ am 31.05.2024
Profil
Dirk Thye is the founder of Pfluent, Inc. (founded in 2011), Peninsula Pharmaceuticals, Inc. (founded in 2001), Cerexa, Inc. (founded in 2005), and Inclin, Inc. (founded in 2007).
Dr. Thye's current job is as the Chief Executive & Medical Officer, Director at Quince Therapeutics, Inc. (since 2022).
Dr. Thye's former jobs include being the President, CEO, CFO, Secretary & Director at Agenovir Corp.
(2016-2018), Chief Executive Officer & Director at Novosteo, Inc. (2021-2022), Executive Chairman at Geom Therapeutics, Inc. (2016-2020), Director at Kalyra Pharmaceuticals, Inc., Manager-Business Process at Quality Planning Corp (2007-2008), and Chief Medical Officer at Cidara Therapeutics, Inc. (2014-2016).
Dr. Thye's education includes a graduate degree from the University of California, Los Angeles and an undergraduate degree from the University of California, Berkeley.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2024 | 689 441 ( 1,60% ) | 572 236 $ | 31.05.2024 |
Aktive Positionen von Dirk Thye
| Unternehmen | Position | Beginn |
|---|---|---|
| QUINCE THERAPEUTICS, INC. | Vorstandsvorsitzender | 19.05.2022 |
Ehemalige bekannte Positionen von Dirk Thye
| Unternehmen | Position | Ende |
|---|---|---|
Novosteo, Inc.
 Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Vorstandsvorsitzender | 01.05.2022 |
Geom Therapeutics, Inc.
 Geom Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Geom Therapeutics, Inc. operates as a biotechnology company focused on the development of novel antibiotics for MDR gram-negative infections. The company is headquartered in San Francisco, CA. | Gründer | 01.07.2020 |
Agenovir Corp.
 Agenovir Corp. Pharmaceuticals: MajorHealth Technology Agenovir Corp. provides research and developing novel antiviral therapeutics for diseases. The company was founded by Bruce Hironaka and Stephen R. Quake and is headquartered in San Francisco, CA. | Vorstandsvorsitzender | 01.01.2018 |
| CIDARA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 02.09.2016 |
| Pfluent, Inc. | Gründer | 01.03.2014 |
Ausbildung von Dirk Thye
| University of California, Berkeley | Undergraduate Degree |
| University of California, Los Angeles | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CIDARA THERAPEUTICS, INC. | Health Technology |
| QUINCE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 9 |
|---|---|
Cerexa, Inc.
 Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | Health Technology |
Peninsula Pharmaceuticals, Inc.
 Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA. | Commercial Services |
Kalyra Pharmaceuticals, Inc.
 Kalyra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kalyra Pharmaceuticals, Inc. manufactures small molecule drugs. The company was founded by Brian T. Dorsey, Cam L. Garner and Kevin Bunker and is headquartered in San Diego, CA. | Health Technology |
| Pfluent, Inc. | |
Inclin, Inc.
 Inclin, Inc. Miscellaneous Commercial ServicesCommercial Services Inclin, Inc. engages in a pharmaceuticals and biotechnology companies. It provides biometrics, clinical operations, strategic consulting, medical writing, quality assurance, drug safety, and medical monitoring services. The company was founded by Taylor Kilfoil and Arnold Wong in 1998 and is headquartered in San Mateo, CA. | Commercial Services |
Quality Planning Corp
 Quality Planning Corp Insurance Brokers/ServicesFinance Part of Verisk Analytics, Inc., Quality Planning Corp provides analytic methods to insurance companies for auto insurance ratings. The company is based in San Francisco, CA. Quality Planning was acquired by Insurance Services Office, Inc. on January 28, 2004. | Finance |
Agenovir Corp.
Agenovir Corp. Pharmaceuticals: MajorHealth Technology Agenovir Corp. provides research and developing novel antiviral therapeutics for diseases. The company was founded by Bruce Hironaka and Stephen R. Quake and is headquartered in San Francisco, CA. | Health Technology |
Geom Therapeutics, Inc.
Geom Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Geom Therapeutics, Inc. operates as a biotechnology company focused on the development of novel antibiotics for MDR gram-negative infections. The company is headquartered in San Francisco, CA. | Commercial Services |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Health Technology |
